Dose escalation schema
aOne patient was unevaluable for dose-limiting toxicity assessment because of underlying illness.
bPatients were enrolled simultaneously on dose levels 2 and 3.
Sign In or Create an Account
This PDF is available to Subscribers Only
For full access to this pdf, sign in to an existing account, or purchase an annual subscription.